Resistance Patterns from Urine Cultures in Children Aged 0 to 6 Years: Implications for Empirical Antibiotic Choice

References

• Millner R, Becknell B. Urinary tract infections. Pediatr Clin North Am. 2019;66:1–13. doi:10.1016/j.pcl.2018.08.00230454735
   PubMed Web of Science ®Google Scholar
• Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin North Am. 2006;53:379–400. doi:10.1016/j.pcl.2006.02.01116716786
   PubMed Web of Science ®Google Scholar
• Roberts KB; Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–610.21873693
   PubMed Web of Science ®Google Scholar
• Okarska-Napierała M, Wasilewska A, Kuchar E. Urinary tract infection in children: diagnosis, treatment, imaging - comparison of current guidelines. J Pediatr Urol. 2017;13:567–573. doi:10.1016/j.jpurol.2017.07.01828986090
   PubMed Web of Science ®Google Scholar
• Stein R, Dogan HS, Hoebeke P, et al. European society for pediatric urology. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015;67:546–558. doi:10.1016/j.eururo.2014.11.00725477258
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women’s and Children’s Health. Urinary tract infection in children: diagnosis, treatment and long-term management; 2007. Available from: http://guidance.nice.org.uk/CG54. Accessed 1111, 2020.
   Google Scholar
• Ammenti A, Alberici I, Brugnara M, et al. Italian society of pediatric nephrology. Updated Italian recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in young children. Acta Paediatr. 2020;109:236–247. doi:10.1111/apa.1498831454101
   PubMed Web of Science ®Google Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74:417–433. doi:10.1128/MMBR.00016-1020805405
   PubMed Web of Science ®Google Scholar
• Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ. 2016;352:i939. doi:10.1136/bmj.i93926980184
   PubMed Web of Science ®Google Scholar
• Erol B, Culpan M, Caskurlu H, et al. Changes in antimicrobial resistance and demographics of UTIs in pediatric patients in a single institution over a 6-year period. J Pediatr Urol. 2018;14:176.e1–176.e5. doi:10.1016/j.jpurol.2017.12.002
   Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66. doi:10.1016/S1473-3099(18)30605-430409683
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases. Available from: https://atlas.ecdc.europa.eu/public/index.aspx. Accessed 1111, 2020.
   Google Scholar
• Calzi A, Grignolo S, Caviglia I, et al. Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children. Eur J Pediatr. 2016;175:1219–1225. doi:10.1007/s00431-016-2763-127558493
   PubMed Web of Science ®Google Scholar
• McWilliam SJ, Antoine DJ, Smyth RL, Pirmohamed M. Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol. 2017;32:2015–2025. doi:10.1007/s00467-016-3533-z27848094
   PubMed Web of Science ®Google Scholar
• Zappitelli M, Moffett BS, Hyder A, Goldstein SL. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant. 2011;26:144–150. doi:10.1093/ndt/gfq37520591815
   PubMed Web of Science ®Google Scholar
• Begg EJ, Barclay ML. Aminoglycosides–50 years on. Br J Clin Pharmacol. 1995;39:597–603.7654476
   PubMed Web of Science ®Google Scholar
• Daikos GL, Jackson GG, Lolans VT, Livermore DM. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis. 1990;162:414–420. doi:10.1093/infdis/162.2.4142115555
   PubMed Web of Science ®Google Scholar
• Arshad M, Seed PC. Urinary tract infections in the infant. Clin Perinatol. 2015;42:17–28. doi:10.1016/j.clp.2014.10.00325677994
   PubMed Web of Science ®Google Scholar
• Didier C, Streicher MP, Chognot D, et al. Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr. 2012;171:681–687. doi:10.1007/s00431-011-1639-722134805
   PubMed Web of Science ®Google Scholar
• Agenzia Regionale Sanità Toscana. I profili di antibiotico-resistenza: le urinocolture; 2018. Available from: https://www.ars.toscana.it/images/pubblicazioni/Collana_ARS/2019/set_diapositive_resistenze_2018_urinocolture.ppt. Accessed 1111, 2020.
   Google Scholar
• Agenzia Italiana del Farmaco. L’uso degli antibiotici in Italia; 2018. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2894_allegato.pdf. Accessed 1111, 2020.
   Google Scholar
• De Rosa R, Avolio M, Stano P, Modolo ML, Camporese A. Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption. Infez Med. 2009;17:82–87.19602920
   PubMedGoogle Scholar
• Montagnani F, Stolzuoli L, Croci L, et al. Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region. Infection. 2009;37:353–357. doi:10.1007/s15010-008-8023-119137242
   PubMed Web of Science ®Google Scholar
• Gherardi G, Petrelli D, Di Luca MC, et al. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy. Eur J Clin Microbiol Infect Dis. 2015;34:1797–1802. doi:10.1007/s10096-015-2414-x26024763
   PubMed Web of Science ®Google Scholar
• Mancini A, Pucciarelli S, Lombardi FE, Barocci S, Pauri P, Lodolini S. Differences between community - and hospital - acquired urinary tract infections in a tertiary care hospital. New Microbiol. 2020;43:17–21.31814033
   PubMed Web of Science ®Google Scholar
• Fan NC, Chen HH, Chen CL, et al. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect. 2014;47:399–405. doi:10.1016/j.jmii.2013.05.00623834784
   PubMedGoogle Scholar
• Albaramki JH, Abdelghani T, Dalaeen A, et al. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: risk factors and antibiotic resistance. Pediatr Int. 2019;61:1127–1132. doi:10.1111/ped.1391131206219
   PubMed Web of Science ®Google Scholar
• Uyar Aksu N, Ekinci Z, Dündar D, Baydemir C. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: risk factors and empiric therapy. Pediatr Int. 2016;59:176–180. doi:10.1111/ped.1311227501161
   PubMed Web of Science ®Google Scholar
• Birgy A, Levy C, Bidet P, et al. ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015. J Antimicrob Chemother. 2016;71:2949–2956. doi:10.1093/jac/dkw21927330068
   PubMed Web of Science ®Google Scholar
• Bryce A, Costelloe C, Wootton M, Butler CC, Hay AD. Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study. J Antimicrob Chemother. 2018;73:1359–1367. doi:10.1093/jac/dkx52529385442
   PubMed Web of Science ®Google Scholar